Cyclo Therapeutics to Present at the NNPDF-INPDA Conferences 2022

Author's Avatar
Jul 21, 2022

Cyclo+Therapeutics%2C+Inc. (Nasdaq: CYTH) (“Cyclo Therapeutics” or the “Company”), a clinical stage biotechnology company dedicated to developing life-changing medicines through science and innovation for patients and families living with diseases, today announced that it will participate at the 30%3Csup%3Eth%3C%2Fsup%3E+Annual+NNPDF+Family+Support+%26amp%3B+Medical+Conference+in+conjunction+with+the+INPDA+Biennial+Meeting being held July 28-31, 2022, in Orlando, FL.